.Merck & Co.'s TIGIT plan has actually gone through an additional misfortune. Months after shutte...
.After a year described through pipe hairstyles, the shift of its own chief executive officer and al...
.Cullinan Therapeutics was excited sufficient with Port BioMed's bispecific immune reactor that it g...
.In this week's incident of "The Best Pipe," we're diving right into Fierce Biotech's annual Intense...
.The confetti is still flying from Eli Lilly's celebration celebrating the approval of Alzheimer's c...
.Accept to this week's Chutes & Ladders, our summary of considerable leadership hirings, shooting...
.Adhering to an unsatisfactory showing for Lykos Therapies' MDMA candidate for trauma at a current F...
.AN2 Rehabs is rethinking its own organization in response to poor midphase records, swearing to lay...
.Merck & Co. is actually paying out $700 thousand upfront to test Amgen in a blood cancer cells m...
.Along With Gilead Sciences on the verge of an FDA decision for its own liver disease medicine selad...